Visit Neurobit Research

Revolutionizing Sleep and Population Health Research using Sleep as a Biomarker

Sleep Research

The Hidden Mortality Risk of Daytime Insomnia Symptoms

This blog delves into a groundbreaking study by Dr. Andrew H. Smith, published in Scientific Reports, which sheds light on the link between insomnia symptoms and increased mortality risk. The research emphasizes the importance of understanding the intricacies of sleep health and its broader implications. Insomnia, a prevalent concern worldwide, poses both a nuisance and a significant health issue, being associated with various health problems.

By Neurobit Health,

By Neurobit Health,

June 19, 2023

June 19, 2023

Share:

Increased mortality risk associated with insomnia symptoms may be entirely driven by the presence of daytime symptoms, reveals Dr. Andrew H. Smith, the lead author of a groundbreaking study published in Scientific Reports. The research, conducted at Flinders University, aims to determine whether insomnia symptoms were associated with an increased mortality risk, emphasizing the importance of understanding sleep health and its implications.

Insomnia is a prevalent issue affecting millions worldwide, with symptoms including difficulty falling asleep, staying asleep, and experiencing restorative sleep. This condition is not only a nuisance but also a significant health concern, as it has been linked to various health problems, including cardiovascular disease and mental health disorders. This issue aligns with Neurobit's focus on innovative sleep health solutions, aiming to improve the quality of sleep and the overall health of individuals.

The study involved a comprehensive analysis of insomnia symptoms and their association with mortality risk. The researchers divided the symptoms into nocturnal (night-time) and daytime categories and found that the increased mortality risk was entirely driven by daytime symptoms. Interestingly, no association was found between night-time symptoms and mortality risk.

The implications of these findings are profound. They suggest that the impact of insomnia on health and mortality may be more complex than previously thought. The focus on daytime symptoms highlights the need for a more nuanced understanding of insomnia and its effects on health. This also underscores the potential of Neurobit's offerings to address these issues by providing comprehensive sleep health solutions.

The study acknowledges several limitations, including not controlling for the chronicity of insomnia symptoms and the presence of other sleep disorders. These factors could potentially influence the reported associations between insomnia symptoms and mortality risk. However, these challenges highlight how Neurobit's solutions can help overcome these limitations by providing detailed sleep analysis and personalized guidance.


Neurobit offers innovative products that can help address the challenges identified in the study:

  1. Neurobit Score: An AI and deep learning platform for accurate sleep event labeling, which can help in understanding the severity and frequency of insomnia symptoms.

  2. Z3 Pulse: A wearable ECG device for comprehensive sleep reports and personalized guidance, which can help in managing insomnia symptoms and improving sleep health.

  3. Neurobit Hub: A platform for collecting and analyzing extensive datasets, promoting the discovery of novel biomarkers and sleep-centric treatment strategies.


Each product contributes uniquely to addressing the identified challenges.

The importance of the study lies in its potential to reshape our understanding of insomnia and its impact on health. Neurobit's technology can play a crucial role in addressing related issues and offering benefits for users, clinicians, and researchers.

We invite readers to learn more about Neurobit's innovative solutions, try our technology, and join us in our mission to improve sleep health. For more information, please contact us at Research@Neurobit.com.


Citation:

Harvey, A., Scott, H., Melaku, Y. A., Lack, L., Sweetman, A., Micic, G., & Lovato, N. (2023). The mortality risk of night-time and daytime insomnia symptoms in an older population. Scientific Reports, 13(1), 9575. https://doi.org/10.1038/s41598-023-36016-4

Neurobit for Research

Neurobit for Research

Scalable solutions for physiological data collection, sleep scoring, and biomarker analysis for researchers

Scalable solutions for physiological data collection, sleep scoring, and biomarker analysis for researchers

Revolutionizing Sleep and Population Health Research using Sleep as a Biomarker

Revolutionizing Sleep and Population Health Research using Sleep as a Biomarker

Revolutionizing data management & analysis in sleep health and population health research.

Clinically validated, fully featured, AASM compliant, Cloud-AI powered automatic sleep scoring system.

Neurobit for Research

Scalable solutions for physiological data collection, sleep scoring, and biomarker analysis for researchers

© 2023 Neurobit Inc. All Rights Reserved.

Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE NOR PURPORTS TO DO SO. The contents of this website are meant purely for informational and educational purposes only. The website is not a substitute for medical advice, diagnosis, treatment or professional care. If you have or suspect you have a health problem, you should consult a doctor or a qualified healthcare provider. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

© 2023 Neurobit Inc. All Rights Reserved.

Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE NOR PURPORTS TO DO SO. The contents of this website are meant purely for informational and educational purposes only. The website is not a substitute for medical advice, diagnosis, treatment or professional care. If you have or suspect you have a health problem, you should consult a doctor or a qualified healthcare provider. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Company

Our Products

Resources

Neurobit for

Partnerships

Email us at

More

© 2023 Neurobit Inc. All Rights Reserved.

Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE NOR PURPORTS TO DO SO. The contents of this website are meant purely for informational and educational purposes only. The website is not a substitute for medical advice, diagnosis, treatment or professional care. If you have or suspect you have a health problem, you should consult a doctor or a qualified healthcare provider. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.